CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Muller and Phipps (India) Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Muller and Phipps (India) Ltd
16, Unique Industrial Estate
Off Veer Savarkar Marg
Phone: +91 2226591191p:+91 2226591191 MUMBAI, 400051  India Ticker: 501477501477
Business Summary
Muller and Phipps (India) Limited is an India-based company, which is engaged in the marketing of over-the-counter medical preparation and home care products. The Company’s segment includes Cosmetics/Toiletries, Medicated preparation and food products. The Company's products/services include medicated dental products, ayurvedic skin ointment and home care products. Its medicated dental products include cavisan and cavifast. The Company's ayurvedic skin ointment product is Nixoderm. Its home care product is Alfa Plus. Its wholly owned subsidiaries include Muller and Phipps (Industrial Services) Ltd. and Muller and Phipps Agencies Ltd.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/20233/31/2023Yes----

Industries
SIC Code Description
5122 Drugs, drug proprietaries, and druggists' sundries

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Practicing Company Secretary SanjaySoman
Director Milan B.Dalal 60
Additional Director VennKrishnan 3/11/2019 3/11/2019
3 additional Officers and Directors records available in full report.

General Information
Outstanding Shares: 625,000 (As of 9/30/2023)
Shareholders: 1,979
Stock Exchange: BOM
Fax Number: +91 2226591186


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, April 26, 2024